Rhythm Pharmaceuticals, Inc. - RYTM
About Gravity Analytica
Recent News
- 09.24.2025 - Commercial Readiness for Acquired Hypothalamic Obesity Event
- 09.09.2025 - Morgan Stanley Global Healthcare Conference
- 09.03.2025 - Wells Fargo Healthcare Conference
- 08.27.2025 - Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences
- 08.27.2025 - Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences
- 08.20.2025 - Rhythm Pharmaceuticals Announces FDA Acceptance of sNDA for Setmelanotide in Acquired Hypothalamic Obesity
- 08.20.2025 - Rhythm Pharmaceuticals Announces FDA Acceptance of sNDA for Setmelanotide in Acquired Hypothalamic Obesity
- 08.13.2025 - Canaccord Genuity 45th Annual Growth Conference
- 08.05.2025 - Rhythm Pharmaceuticals 2Q 2025 Earnings Conference Call
- 08.05.2025 - Rhythm Pharmaceuticals Reports Second Quarter 2025 Financial Results and Business Update
Recent Filings
- 08.25.2025 - 4 Statement of changes in beneficial ownership of securities
- 08.21.2025 - 144 Report of proposed sale of securities
- 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
- 08.14.2025 - 4 Statement of changes in beneficial ownership of securities
- 08.14.2025 - 4 Statement of changes in beneficial ownership of securities
- 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
- 08.13.2025 - 4 Statement of changes in beneficial ownership of securities
- 08.12.2025 - 144 Report of proposed sale of securities
- 08.12.2025 - 144 Report of proposed sale of securities
- 08.11.2025 - 144 Report of proposed sale of securities